Finance

Lists
Why is NKTR down 4,01%?
Dive Deeper
NKTR:NASDAQ
Nektar Therapeutics
37,10 $
-4,01%
(-1,55) 1D
23 қаз., 09:58:30 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTR...
Open
37,87 $
High
38,16 $
Low
37,05 $
Mkt. cap
1,27 млрд
Avg. vol.
1,68 млн
Volume
27,40 мың
52-wk high
109,00 $
52-wk low
33,40 $
EPS
-6,69 $
Beta
1,26
Shares outstanding
34,14 млн
No. of employees
63
Open
37,87 $
High
38,16 $
Low
37,05 $
Mkt. cap
1,27 млрд
Avg. vol.
1,68 млн
Volume
27,40 мың
52-wk high
109,00 $
52-wk low
33,40 $
EPS
-6,69 $
Beta
1,26
Shares outstanding
34,14 млн
No. of employees
63
News stories
From web sources and news partners
About Nektar Therapeutics
CEO-
Employees63
Founded1990
HeadquartersСан Франсиско, Калифорния, Америка Құрама Штаттары
Sector-
Websitenektar.com
Analyst ratings
Based on 14 analysts giving stock ratings to NKTR in the past 3 months
Buy
Buy
10
Hold
4
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for NKTR in the last 3 months.
Highest
Current 37,10 $
192,00 $ (+417,52%)
Average
132,45 $ (+257,01%)
Lowest
50,00 $ (+34,77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
192,00 $
+417,5%
10/22/2026
Will Soghikian
Leerink Partners
Buy
Initiated
130,00 $
+250,4%
10/12/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
130,00 $
+250,4%
10/12/2026
Alice Nettleton
UBS
Hold
Initiated
53,00 $
+42,9%
10/12/2026
Julian Harrison
BTIG
Buy
Maintained
178,00 $
+379,8%
10/09/2026
Thomas Deal
Raymond James
Hold
Initiated
-
-
10/08/2026
Unknown Analyst
Raymond James
Hold
Initiated
-
-
10/08/2026
Samantha Semenkow
Citi
Buy
Reiterated
151,00 $
+307%
10/05/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
150,00 $
+304,3%
10/02/2026
Roger Song
Jefferies
Buy
Maintained
150,00 $
+304,3%
10/01/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
10/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
185,00 $
+398,7%
10/02/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
153,00 $
+312,4%
09/28/2026
Martin Fan
Wedbush
Hold
Reiterated
50,00 $
+34,8%
09/23/2026
Jessica Fye
J.P. Morgan
Hold
Initiated
65,00 $
+75,2%
08/21/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/13/2026
Jay Olson
Oppenheimer
Buy
Maintained
140,00 $
+277,4%
05/08/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
150,00 $
+304,3%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
11,79 млн
21,81 млн
10,86 млн
10,13 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
27,25 млн
29,71 млн
35,68 млн
39,13 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,07 млн
11,18 млн
13,44 млн
12,76 млн
Operating expense
43,32 млн
40,90 млн
49,12 млн
51,89 млн
Total operating expenses
43,32 млн
40,90 млн
49,12 млн
51,89 млн
Operating income
-31,53 млн
-19,09 млн
-38,26 млн
-41,76 млн
Other non operating income
-121,00 м.
-44,00 мың
-336,00 м.
-100,00 м.
EBT including unusual items
-35,56 млн
-36,05 млн
-44,84 млн
-40,62 млн
EBT excluding unusual items
-35,42 млн
-27,47 млн
-44,04 млн
-40,04 млн
Income tax expense
-33,00 мың
31,00 мың
64,00 мың
2,00 мың
Effective tax rate
0,09%
-0,09%
-0,14%
-
Other operating expenses
-
-
-
-
Net income
-35,52 млн
-36,08 млн
-44,90 млн
-40,62 млн
Net profit margin
-301,29%
-165,45%
-413,44%
-400,97%
Earnings per share
-1,87
-1,29
-1,78
-1,21
Interest and investment income
2,82 млн
2,78 млн
4,24 млн
9,35 млн
Interest expense
-6,05 млн
-9,77 млн
-7,94 млн
-7,21 млн
Net interest expenses
-3,23 млн
-6,99 млн
-3,70 млн
2,14 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,34 млн
-18,90 млн
-38,11 млн
-41,61 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары